22 results
8-K
EX-99.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
with riluzole in a transgenic mouse model of ALS.
In November 2023, the Company presented new preclinical data at the Society for Neuroscience (SfN) Annual
8-K
EX-99.1
ATHA
Athira Pharma Inc
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
by the Society for Neuroscience and will take place at the Walter E. Washington Convention Center in Washington, D.C., November 11-15, 2023
8-K
EX-99.1
ATHA
Athira Pharma Inc
10 Nov 22
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:11pm
in preclinical models.
Upcoming data presentations at scientific meetings
At the Society for Neuroscience 2022 Annual Meeting (November 12-16, 2022
8-K
EX-99.1
ATHA
Athira Pharma Inc
15 Aug 22
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:35pm
for the potential treatment of Alzheimer’s disease and other neurodegenerative disorders.
Preclinical Data Presented at Peripheral Nerve Society (PNS) 2022 Annual
8-K
EX-99.1
52k7bp5jri
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DEFA14A
iav5h0lwwax na7adj7s
26 Apr 22
Additional proxy soliciting materials
8:11am
DFAN14A
EX-99.3
gzr0620ax
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFA14A
00gx nm1pdjz5xi
5 Apr 22
Additional proxy soliciting materials
5:03pm
8-K
EX-99.1
0nhf8k5vt 4g
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
91s13
9 Aug 21
Other Events
6:06am
8-K
EX-99.1
yssgg2u2xwn42xbx5a
9 Aug 21
Other Events
6:06am
DEF 14A
5jg9eh57jozsdxbwz1y
16 Apr 21
Definitive proxy
6:02am
10-K
m1gi 92s2
25 Mar 21
Annual report
12:00am
424B4
bb2ptpciu5gwrad
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
ht9tj9drl
6 Jan 21
Draft registration statement
12:00am
424B4
1oas00r
18 Sep 20
Prospectus supplement with pricing info
4:05pm